Specifically, SSTR5 activates the MEK-ERK, Jun N-terminal kinase (JNK) and p38 pathways to mediate proliferation arrest (Figure 2), and affects differentiation, apoptosis, anti-angiogenesis and tumor metabolism. The gene discussed is SSTR5; the disease is neoplasm.